Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

REGN Regeneron Pharmaceuticals

Market Closed 08-28 16:00:00 EDT

794.19

-13.52

-1.67%

盘后797.00

+2.81+0.35%

19:44 EDT

High809.40	Low789.08	Vol488.31K
Open809.40	D1 Closing807.71	Amplitude2.52%
Mkt Cap81.77B	Tradable Cap78.53B	Total Shares102.95M
T/O387.71M	T/O Rate0.49%	Tradable Shares98.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":794.19,"timestamp":1787947200000,"preClose":807.71,"halted":0,"volume":488305,"hourTrading":{"tag":"盘后","latestPrice":797,"preClose":794.19,"latestTime":"19:44 EDT","volume":10275,"amount":8161679.2026,"timestamp":1787960643834,"change":2.81,"changeRate":0.003538,"amplitude":0.003538},"delay":0,"changeRate":-0.01673868096222652,"floatShares":98883600,"shares":102954988,"eps":40.43335,"marketStatus":"Market Closed","change":-13.52,"latestTime":"08-28 16:00:00 EDT","open":809.4,"high":809.4,"low":789.075,"amount":387706552.44200003,"amplitude":0.025164,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":40.43335,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":807.71,"dividendRate":0.004583,"preHourTrading":{"tag":"盘前","latestPrice":810,"preClose":807.71,"latestTime":"09:19 EDT","volume":3084,"amount":2491453.93296,"timestamp":1787923144798,"change":2.29,"changeRate":0.002835,"amplitude":0.046787},"postHourTrading":{"tag":"盘后","latestPrice":797,"preClose":794.19,"latestTime":"19:44 EDT","volume":10275,"amount":8161679.2026,"timestamp":1787960643834,"change":2.81,"changeRate":0.003538,"amplitude":0.003538},"volumeRatio":0.7361270195022234,"impliedVol":0.2964,"impliedVolPercentile":0.1155},"requestUrl":"/m/hq/s/REGN/tweets","defaultTab":"tweets","newsList":[{"id":"2663301537","title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663301537","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663301537?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:43","pubTimestamp":1787949780,"startTime":"0","endTime":"0","summary":"DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  slipped 1.67% to $794.19 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's third consecutive day of losses.Regeneron Pharmaceuticals Inc. closed 6.23% below its 52-week high of $847.00, which the company reached on August 21st.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc.  fell 1.05% to $432.42, Moderna Inc.  fell 3.35% to $137.99, and Gilead Sciences Inc.  fell 2.14% to $145.68.Trading volume  remained 367,151 below its 50-day average volume of 854,270.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708043","title":"China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708043","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708043?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:08","pubTimestamp":1787825320,"startTime":"0","endTime":"0","summary":"China's JW Therapeutics interim revenue rises 4.7% on Carteyva salesOverviewChina cell immunotherapy developer's interim revenue grew 4.7% yr/yr, driven by Carteyva salesGross profit margin improved t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU0395794307.EUR","JDOC","AGNG","MEDX","BK1574","LU1934455277.USD","GLAM","LU0859254822.USD","LU0943347566.SGD","LU1188198961.HKD","LU1037948897.HKD","IE000SO60NU8.SGD","IE00BN8TJ469.HKD","LU0463099449.HKD","LU2362541513.USD","03692","FTXH","02126","LU0708994859.HKD","IE0004445239.USD","LU0310799852.SGD","LU0432979614.USD","LU0949170772.SGD","TBXU","VHT","PJP","RXL","IXJ","LU2237443978.SGD","IYH","MADE","KURE","LU1934455863.HKD","XLV","LU2097828714.EUR","IBBQ","IBB","TRUH","LU1244550577.SGD","688331","ABBV","LU0868494617.USD","CMI","01801","PPH","IE00BVYPNV92.GBP","REGN","BBH","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708397","title":"JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708397","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708397?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:58","pubTimestamp":1787824692,"startTime":"0","endTime":"0","summary":"JW Cayman Therapeutics FY26 H1 IFRS loss narrows 81.14% to RMB 50.4 million; revenue rises 4.7% to RMB 111.4 millionJW Cayman Therapeutics posted IFRS revenue of RMB 111.4 million, up 4.7% year over y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8Yh1j4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU0823434583.USD","LU2106854487.HKD","LU0053666078.USD","LU0114720955.EUR","IBBQ","BBH","LU0823434740.USD","LU2468319806.SGD","LU0882574055.USD","LU1974910355.USD","LU2362541273.HKD","LU2362540622.SGD","BK1161","LU0320765992.SGD","02126","LU2023250504.SGD","LU2089984988.USD","LU2362541513.USD","LU0058720904.USD","LU0109394709.USD","LU0289739699.SGD","LU0889565916.HKD","TBXU","BK1574","BK1583","BK4585","BK4588","IBB","LU2237438978.USD","BK4139","LU1917777945.USD","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662514775","title":"AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662514775","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662514775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:40","pubTimestamp":1787812818,"startTime":"0","endTime":"0","summary":"UPDATE 3-AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trialAug 27 (Reuters)-AstraZenecaAZN.Lsaid on Thursday its asthma drug Tezspire met the main goals of a late-stage tria","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU1170363599.USD","LU0122379950.USD","IBB","LU3187612489.SGD","LU0345777659.USD","LU1829250122.USD","BIB","IE00BFTCPJ56.SGD","LU1974910355.USD","LU1119994496.HKD","LU0052756011.USD","LU0972486137.USD","LU2237443382.USD","IBBQ","SGXZ57979304.SGD","BBH","TBXU","LU0738911758.USD","LU1481600234.SGD","PJP","LU0792757196.USD","AZN.UK","LU0997586432.USD","LU0266013472.USD","LU0310799852.SGD","LU0887340254.USD","LU0047473722.EUR","LU1057294990.SGD","LU0640478417.SGD","LU0997586515.USD","PBE","LU1153584641.USD","BK4588","LU2237443622.USD","LU1880407132.USD","REGN","BK4599","LU1003077747.HKD","LU1267930490.SGD","LU0823434583.USD","LU1051770623.HKD","LU0077335932.USD","LU2242652126.USD","LU2293690082.USD","LU0661504455.SGD","AMGN","LU0575583348.USD","03165","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662742550","title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662742550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662742550?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:43","pubTimestamp":1787776980,"startTime":"0","endTime":"0","summary":"DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  shed 2.25% to $814.79 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,675.70 and Dow Jones Industrial Average  falling 0.21% to 53,463.88.Regeneron Pharmaceuticals Inc. closed 3.80% short of its 52-week high of $847.00, which the company reached on August 21st.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc.  fell 0.43% to $440.34, Moderna Inc.  fell 5.77% to $149.66, and Gilead Sciences Inc.  fell 0.46% to $148.09.Trading volume  remained 280,671 below its 50-day average volume of 863,690.Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662423737","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662423737","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662423737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:15","pubTimestamp":1787663703,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF  slightly advancing and the iShares Biotechnology ETF  up 0.2%.Immatics  shares were up more than 13% after the company said it has agreed to sell about 12.9 million ordinary shares at $8.69 each, and in lieu of ordinary shares to certain investors, pre-funded warrants to buy up to approximately 4.3 million ordinary shares at $8.689 per pre-funded warrant.Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to statements from Veeva. Shares of Veeva Systems were down 0.1% premarket.Bausch + Lomb  stock was up more than 1% after the company said it plans to advance two of its pharmaceutical pipeline assets to new trials based on latest clinical results.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0053666078.USD","LU0823434740.USD","LU0109394709.USD","XBI","BK4504","BK4528","IBB","LU0882574055.USD","LU0114720955.EUR","LU2362541273.HKD","LU0289739699.SGD","BK4581","LU0234570918.USD","BMED","LU1974910355.USD","LU0320765992.SGD","BK4533","IBBQ","XLV","BK4198","BBH","IMTX","LU2362540622.SGD","LU0128526141.USD","TBXU","BLCO","BIIB","BK4139","VEEV","LU2468319806.SGD","LU2089984988.USD","LU0029874061.USD","LU0889565916.HKD","IE00B19Z9P08.USD","LU2237438978.USD","PBE","BK4588","BK4532","REGN","LU2023250504.SGD","LU0058720904.USD","LU0170899867.USD","BK4534","HCSG","LU1917777945.USD","BK4613","LGHT","EKG","IE00B894F039.SGD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662673234","title":"Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662673234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662673234?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:37","pubTimestamp":1787661420,"startTime":"0","endTime":"0","summary":"Underappreciated value stocks provide 'ballast' for investors, says Bank of AmericaEstée Lauder earns a rank among high-growth stocks beyond AI.In 2021 strategists at Bank of America's BofA Securities","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOW","LU2404859741.USD","CFG","HOOX","LU1699723380.USD","LU0708994859.HKD","LU1506573853.SGD","AAUM","LU1267930490.SGD","MHIP","LU1732800096.USD","LU0211331839.USD","LU2210150020.SGD","LU0545039389.USD","LU0354030511.USD","LU1035773651.USD","BK4154","BK4550","IE00B64PRP62.GBP","FTXO","LU1935042991.SGD","LU0553294199.USD","LU0345770993.USD","LU0210536198.USD","LU0106261372.USD","HRTS","LU2471134796.USD","LU2360032135.SGD","LU2129689514.USD","SG9999014914.USD","LU1430594728.SGD","VFH","IE00BFSS8Q28.SGD","BK4135","LU1983260115.SGD","LU1061106388.HKD","HOOY","LU0963586101.USD","LU2023251221.USD","LU0965509010.AUD","LU1280957306.USD","LU0306806265.USD","LU1935043023.USD","LU1814569148.SGD","LU1791807156.HKD","LU1093756325.SGD","BK4554","LU1935043536.SGD","LU2602419157.SGD","SG9999015978.USD","BBH","SG9999001440.SGD","IHF","LU0238689110.USD","LU0943347566.SGD","BK4127","LU1880398554.USD","LU1720051108.HKD","LU2491050154.USD","LU0130517989.USD","LU2361045086.USD","LU2471134952.CNY","LU1363072403.SGD","LU2264538146.SGD","LU0058720904.USD","IXJ","SG9999015952.SGD","HODU","LU2552382215.SGD","LU0795875169.SGD","LU1023059063.AUD","LU0256863902.USD","LU0289961442.SGD","HOOC","LU0175139822.USD","IE00BFTCPJ56.SGD","IE00B42XCP33.USD","LU0466842654.USD","LU0882574055.USD","BAC","LU0477156953.USD","LU0057025933.USD","LU2065171311.SGD","LU2237443622.USD","IHE","GQRE","BK4207","LU2362541273.HKD","LU2168564495.EUR","HOOD","LU0820561909.HKD","BK4581","LU2125909593.SGD","SG9999014005.SGD","IYF","SGXZ99366536.SGD","KKR","LU2211817866.USD","LU1917777945.USD","BK4503","LU2357305700.SGD","FINX","LU0859254822.USD","CNCG","LU2125154778.USD","SGXZ31699556.SGD","LU1236620750.USD","LGLV","LU0109394709.USD","LU1037948897.HKD","LU0072461881.USD","RXL","LU1868836757.USD","IAI","LU1496350171.SGD","LU0094547139.USD","IE0005OL40V9.USD","BK4566","LU2746668974.SGD","LU0985320562.USD","LU0689472784.USD","BK4139","LU1880398471.USD","BK4106","IE00B19Z3581.USD","LU0432979614.USD","LU2491050071.SGD","IE00BK4W5M84.HKD","LU0316494557.USD","IE00BKPKM429.USD","LU2237443382.USD","BK4598","LU0786609619.USD","LU1201861165.SGD","GDOC","LU2750360997.AUD","LU1989771016.USD","LU2168564222.USD","JRE","LU0728928796.USD","LU1496350502.SGD","SCHH","LU0130518102.USD","RWR","LU0133085943.USD","LU0787776722.HKD","LU0823416689.USD","LU1267930573.SGD","LU0170899867.USD","LU0648001328.SGD","LU2756315318.SGD","IE00B1BXHZ80.USD","IE0034235188.USD","LU0052756011.USD","ICF","PSP","IE00B3PB1722.GBP","IE00BGHQF631.EUR","IE00BKDWB100.SGD","LU1244550494.USD","LU1894683348.USD","LU2111349929.HKD","LU0029864427.USD","LU0162691827.USD","LU2210149790.SGD","ARES","REIX","LU1934455194.USD","LU2347655156.SGD","LU0708995401.HKD","CANC","GB00BDT5M118.USD","LU0310800379.SGD","LU2237438978.USD","ELIS","IE00BGHQF748.EUR","LU0266013472.USD","LU0109391861.USD","HUM","LU2237957811.SGD","IE0002270589.USD","FHLC","LU1629891620.HKD","LU2125154935.USD","LU0640476718.USD","LU2596442595.SGD","VGSR","BK4227","LU0158827781.USD","LU0345770308.USD","LU1084165304.USD","BPAY","LU1732799900.SGD","SG9999014013.SGD","BK4558","LU1670628061.USD","IE00BDGV0183.EUR","IE00BJJMRX11.SGD","REIT","LU2236285917.USD","LU1267930227.SGD","LU2129689605.HKD","SG9999014898.SGD","LU0128525929.USD","BK4547","LU2065171402.SGD","LU2095319765.USD","LU0868494617.USD","LU1093756168.USD","REZ","LU0738911758.USD","LU1585245621.USD","LU2211815571.USD","PRVT","LU0456855351.SGD","ERET","ELIL","GPZ","IE00B2B36J28.USD","LU0323591593.USD","LU2552382132.HKD","TMED","LU1868837136.USD","LU1974910355.USD","IE00BSNM7G36.USD","LU1037948541.HKD","HOII","LU2361044865.SGD","LU2023250330.USD","LU0203345920.USD","LU2265009873.SGD","LU2106854487.HKD","SG9999013999.USD","SG9999001176.SGD","LU2471134879.HKD","LU2756315664.SGD","IE00BZ1G4Q59.USD","LU0124676726.USD","BK4553","TFNS","LU0098860793.USD","LU0158827948.USD","LU2552382058.USD","SGXZ51526630.SGD","LU0070302665.USD","LU2065170008.USD","LU1861559042.SGD","LU1074936037.SGD","SG9999017495.SGD","IE00BLSP4452.SGD","LU1923622614.USD","IE00BJJMRY28.SGD","LU1244550221.USD","LU0289739699.SGD","LU0006306889.USD","LU0820561818.USD","LU0061475181.USD","LU0882574139.USD","MEDI","IE0004445015.USD","LU2417539215.USD","LU2089284900.SGD","LU1934455863.HKD","USRT","LU1232071149.USD","LU0690374961.EUR","LU0106831901.USD","BK4534","LU2271345857.HKD","WDNA","CNC","IE0001KFT4U8.USD","LU0289739343.SGD","IE00BFXG1179.USD","LU1323610961.USD","LU0823434740.USD","SG9999001176.USD","LU1989772923.USD","LU0053666078.USD","BK4599","HOYY","LU0868494708.USD","XLF","LU2360106947.USD","IE00BN29S564.USD","LU2089283258.USD","TRUR","LU2168564149.EUR","LU0471298777.SGD","LU1894683264.USD","LU0942090050.USD","LU0306807586.USD","LU0069063385.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","IE00B4R5TH58.HKD","LU2237443895.HKD","LU0971096721.USD","AVRE","URE","IAT","LU1868836914.USD","LU1551013425.SGD","LU1929549753.HKD","EKG","HOOI","SG9999015986.USD","LLYZ","LU0122379950.USD","IE00BHPRN162.USD","SG9999014906.USD","IE00BMPRXN33.USD","LU0965509283.SGD","BYRE","JDOC","LU0353189763.USD","BK4588","LU1839511570.USD","LU0203347892.USD","LU2746668461.USD","LU2023250504.SGD","LU0321505439.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0965508806.USD","LU0354030438.USD","LU0965509101.SGD","LU0225283273.USD","LU2087625088.SGD","LU0395794307.EUR","LU0321505868.SGD","BK4203","LBO","PSR","SG9999011175.SGD","LU0348723411.USD","IE0002141913.USD","LU1261432733.SGD","BBRE","SPRE","LU1244550577.SGD","LU1201861249.SGD","LU2108987350.USD","LU0320765646.SGD","LLII","AGNG","LU0234570918.USD","LU0980610538.SGD","IYRI","LU2468319806.SGD","IYG","IE00B7SZLL34.SGD","IE00BJLML261.HKD","LU1551013342.USD","SG9999018865.SGD","IE00B3QW5Z07.USD","SG9999018857.SGD","LU0353189680.USD","MEDX","LU0310800965.SGD","LU0385154629.USD","LU1720051017.SGD","EL","LU1989772840.SGD","LU0477156797.USD","TBXU","OZEM","HEAL","LU2237957902.USD","IQRA","LU2237443978.SGD","LU2896262040.SGD","LU1267930730.SGD","LU1691799644.USD","LU1366192091.USD","LU1236620834.HKD","LU1162221912.USD","BK4504","DFAR","LU1144417596.USD","LU0096364046.USD","SGXZ81514606.USD","LU1979441026.SGD","LU1988902786.USD","SG9999015945.SGD","HOOZ","LU0672654240.SGD","KBWB","LU1127390331.HKD","IE0004445239.USD","IE00BVYPNW00.USD","LU0211328371.USD","LLY","LU0203201768.USD","LU0648000940.SGD","RWO","ILDR","LU2237443465.HKD","RNTY","LU2404859667.USD","LU2213496289.HKD","DFGR","IBKR","FRI","LLYX","LU1983299246.USD","LU2462591350.SGD","LU1069344957.HKD","LU2324357040.USD","LU2362540622.SGD","LU0130102774.USD","BLCK","LU2462157665.USD","LU0320765059.SGD","LU0912757837.SGD","IE00BFSS7M15.SGD","RSPR","CLIM","LU0198837287.USD","BK4539","IYR","LU2361044949.HKD","BK4211","LU2237443549.SGD","LU2347655073.USD","IE00BK4W5L77.USD","IE00BVYPNV92.GBP","LU0097036916.USD","LU0211327993.USD","LU1712237335.SGD","LU1868837300.USD","UYG","LU0310799852.SGD","LU2491049909.HKD","IE0000B7K699.USD","LU1791710400.SGD","LU0795875086.SGD","LU0690374615.EUR","LU0823434583.USD","LU1064131342.USD","LU0661504455.SGD","LU1035775433.USD","LU1668664300.SGD","LU2168563687.JPY","LU2461242641.AUD","IE000WAW04H5.SGD","LU0314104364.USD","ROBN","WELL","IE00B7KXQ091.USD","REET","LU1145028129.USD","LU0949170772.SGD","LU1935042215.USD","LU0234572021.USD","LU2168564065.EUR","LU1804176565.USD","VNQ","REGN","LU0256863811.USD","FREL","FTXH","IE0009355771.USD","LU1548497426.USD","LU0320765489.SGD","BK4551","DXCM","THNR","IE00BLSP4239.USD","LU0417517546.SGD","CRPT","RITA","DPRE","LU0726765562.USD","XLRE","LU0689626769.HKD","IE00B1XK9C88.USD","CURE","JPRE","GLAM","HOOG","IE00BBT3K403.USD","LU2357627491.SGD","LU1670627923.USD","IE000SO60NU8.SGD","IBB","LU1861558580.USD","IBBQ","LU0208291251.USD","LU2089984988.USD","LU0289960550.SGD","LU0390134368.USD","LU2471134523.USD","LU0128525689.USD","LU1883839398.USD","LU2129689431.USD","LU2433249047.HKD","SG9999003800.SGD","LU2456880835.USD","ABBV","BK4516","LU0889565916.HKD","SG9999014880.SGD","LU0472753341.HKD","IYH","LU0174119429.USD","IE000BZT7R73.USD","PJP","LU1935042488.USD","LU0149725797.USD","LU2112291526.USD","C","LU0528227936.USD","IE00BKVL7J92.USD","VHT","LU1003077747.HKD","LU0320765992.SGD","LU0683600562.USD","IE00BMPRXR70.SGD","BK4559","LU0964807845.USD","LU2028103732.USD","IE000F7OJYX1.SGD","LU1718418525.SGD","LU2087621335.USD","SG9999014021.USD","BK4585","LU0203202063.USD","LU1069347547.HKD","LU2063271972.USD","SGXZ57979304.SGD","IE00BWXC8680.SGD","LU2362541513.USD","BK4183","LU1623119135.USD","LU0861579265.USD","IE00B4JS1V06.HKD","LU2133065610.SGD","LU2750360641.GBP","LU2065169927.USD","FXH","BK4528","BK4225","LU2125909247.SGD","XLV","FNCL","BK4548","LU1119994496.HKD","IE00B775H168.HKD","HAUS","PODD","BK4007","BK4533","LU0314106906.USD","IE00BN8TJ469.HKD","LU1868836591.USD","LU0511384066.AUD","IE00B19Z3B42.SGD","LU0079474960.USD","IE000MB6IJN5.SGD","LU0820562030.AUD","BK4082","LU1291159041.SGD","LU1934455277.USD","LU0130103400.USD","TRUH","PPH","LU0471298694.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731506","title":"Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731506","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731506?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:41","pubTimestamp":1787658092,"startTime":"0","endTime":"0","summary":"Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to Tuesday statements from Veeva.No financial details were disclosed.Biogen will use Veeva Vault CRM as its agentic commercial foundation to deliver drugs to patients, while Regeneron plans to use the platform to generate commercial evidence that will back treatment adoption, Veeva said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4613","LU0823434583.USD","BK4528","LU2089984988.USD","BK4532","LU0823434740.USD","LU0823416689.USD","IBB","BBH","BK4534","LU1917777945.USD","BIIB","LU0289739699.SGD","BK4588","EKG","LU0234570918.USD","LU0889565916.HKD","LU1974910355.USD","LU2106854487.HKD","LU2468319806.SGD","IE00B19Z9Z06.USD","IE00B894F039.SGD","VEEV","LU0266013472.USD","LU2362541273.HKD","LGHT","LU0109394709.USD","LU0170899867.USD","IBBQ","LU0058720904.USD","LU0882574055.USD","REGN","LU0320765992.SGD","LU1989764664.SGD","LU2362541513.USD","BK4585","LU2237438978.USD","BK4167","LU2362540622.SGD","BMED","LU0114720955.EUR","LU0053666078.USD","BK4504","TBXU","LU2023250504.SGD","PBE","IE00B19Z9P08.USD","BK4533","LU1989764748.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662884739","title":"Regeneron Selects Veeva Vault CRM for Global Rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=2662884739","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662884739?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:06","pubTimestamp":1787656004,"startTime":"0","endTime":"0","summary":"Regeneron selects Veeva Vault CRM for global rolloutRegeneron committed to deploy Veeva Vault CRM globally, extending an existing strategic partnership.Rollout targets AI-powered field engagement to g","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL2yh8x5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU2362541513.USD","VEEV","BK4613","LU0109394709.USD","LU2362541273.HKD","LU1917777945.USD","LU2362540622.SGD","LU0170899867.USD","BK4585","IBBQ","BK4588","LU0320765992.SGD","LU0882574055.USD","LU1989764664.SGD","LU1974910355.USD","LU2106854487.HKD","LU0889565916.HKD","LU0266013472.USD","LU2237438978.USD","LU0289739699.SGD","LU0823434740.USD","EKG","BK4504","LU1989764748.USD","LU2089984988.USD","REGN","LU0058720904.USD","LU0823434583.USD","BK4139","BK4534","BK4167","LU2468319806.SGD","BBH","LU2023250504.SGD","BK4528","IBB","LGHT","TBXU","LU0114720955.EUR","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302215","title":"Regeneron Pharmaceuticals (REGN) Wins Pasatru Approval, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302215","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302215?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362233,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) stock moved after the U.S. Food and Drug Administration approved Pasatru for adults with fibrodysplasia ossificans progressiva. This new rare disease therapy is supported by late stage OPTIMA trial data.\nSee our latest analysis for Regeneron Pharmaceuticals.\nThe Pasatru approval comes after a strong run in Regeneron Pharmaceuticals’ stock, with a 30.55% 90 day share price return and a 42.21% 1 year total shareholder return, suggesting recent momentum after...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-wins-pasatru-approval-is-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-wins-pasatru-approval-is-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0882574055.USD","BK4139","BK4588","LU2237438978.USD","LU2362541513.USD","LU0823434740.USD","LU2023250504.SGD","LU0823434583.USD","LU2089984988.USD","LU2362541273.HKD","LU2468319806.SGD","LU0114720955.EUR","LU1917777945.USD","LU0320765992.SGD","IBBQ","LU0289739699.SGD","REGN","TBXU","LU2106854487.HKD","LU1974910355.USD","BK4585","IBB","LU0889565916.HKD","LU2362540622.SGD","DCF","LU0058720904.USD","BBH","LU0823416689.USD","LU0053666078.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","REGN","LU1093756325.SGD","SG9999013999.USD","LU0859254822.USD","BIB","IBBQ","BK4568","LU0154245673.USD","SG9999001440.SGD","BBH","LU1430594728.SGD","IE00B894F039.SGD","LU0882574055.USD","LU2468319806.SGD","BK4583","LU0868494617.USD","LU1983299246.USD","IE00B4R5TH58.HKD","PBE","BK4585","SG9999001176.SGD","IE0002270589.USD","LU2324357040.USD","SG9999015952.SGD","SG9999015986.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU0058720904.USD","BMED","LU0965509101.SGD","MEDI","LU2357627491.SGD","BK4139","IE00B19Z9Z06.USD","LU0823434583.USD","BK4581","XBI","LU1674673691.USD","LU0053666078.USD","LU1934455863.HKD","LU2362541273.HKD","LU0061475181.USD","BK4588","IE00BFTCPJ56.SGD","IDNA","BK4567","LU2087621335.USD","LU2462157665.USD","LU1023059063.AUD","IE00BZ1G4Q59.USD","LU2362540622.SGD","SG9999015978.USD","GILD","LU1061106388.HKD","LU1057294990.SGD","SGXZ57979304.SGD","LU0823434740.USD","LU2242646821.SGD","PJP","BK4578","IBB","LU1069344957.HKD","LU1974910355.USD","IE00B19Z9P08.USD","LU1037948897.HKD","LU0154245756.USD","IE00B2B36J28.USD","LU0965509283.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4534","LU0289739699.SGD","LU1934455194.USD","LU1778281490.HKD","LU1066051498.USD","SG9999015945.SGD","IE0002141913.USD","LU1037948541.HKD","BK4550","LU0256863811.USD","SG9999001176.USD","BK4532","IE00BN0W2V16.EUR","LU0965509010.AUD","LU2417539215.USD","LU1066053197.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0432979614.USD","TMED","BK4599","LU1585245621.USD","LU1917777945.USD","IE00BN0W2W23.USD","AMGN","LU2242652126.USD","IE00B19Z3581.USD","LU2362541513.USD","IE00B7SZLL34.SGD","LU2456880835.USD","IE00B3T34201.USD","LU1934455277.USD","IE00BJT1NW94.SGD","IE00BKVL7J92.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4533","BK4566","IE00BN0W2T93.GBP","LU0861579265.USD","LU0417517546.SGD","JAZZ","LU1093756168.USD","LU1035775433.USD","VRTX","BK4007","LU0079474960.USD","LU2112291526.USD","TBXU","LU0114720955.EUR","LU0965508806.USD","LU0109394709.USD","04332","IE00BZ9MQY76.HKD","LU1839511570.USD","LU2237438978.USD","LU1674673428.USD","LU0823416689.USD","LU0889565916.HKD","LU2236285917.USD","GNMX","LU0234570918.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260437","title":"Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260437?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:58","pubTimestamp":1787313533,"startTime":"0","endTime":"0","summary":"A class action lawsuit was filed against biotechnology company Regeneron ($REGN) on July 16, which could put further pressure on its troubled share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","LU2362541513.USD","DARP","XT","LU0109394709.USD","LU2362541273.HKD","LU1917777945.USD","SYNB","LU2362540622.SGD","JDOC","BK4585","IBBQ","BK4588","LU0320765992.SGD","LNGR","LU0882574055.USD","LU1974910355.USD","LU2106854487.HKD","IEIH","LU0889565916.HKD","LU2237438978.USD","LU0289739699.SGD","LU0823434740.USD","RSPH","LU2089984988.USD","REGN","FHLC","LU0058720904.USD","LU0823434583.USD","BK4139","LU2468319806.SGD","BBH","LU2023250504.SGD","IBB","FWD","BBP","TBXU","AGNG","LU0114720955.EUR","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660340609","title":"Sweden's Medivir Q2 Turnover Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340609","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660340609?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:41","pubTimestamp":1787208103,"startTime":"0","endTime":"0","summary":"Sweden's Medivir Q2 turnover fallsOverviewSweden drug developer's Q2 net turnover declined yr/yr, EBITDA loss narrowedCompany completed SEK 140 mln share issue to fund rare bone disease drug developme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H07I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0823434740.USD","FLEL","LU0889565916.HKD","LU0823434583.USD","LU1720051108.HKD","FLEX","LU0289739343.SGD","LU2357305700.SGD","LU2362541513.USD","LU0963586101.USD","LU0109394709.USD","IBB","LU0511384066.AUD","REGN","BK4139","LU2473716301.USD","LU0823416689.USD","LU0069063385.USD","BK4512","LU1917777945.USD","LU1366192091.USD","LU2322448791.USD","IBBQ","BK4585","BK4588","LU0289739699.SGD","LU0320765489.SGD","LU2322448957.HKD","LU2362540622.SGD","LU0208291251.USD","LU0114720955.EUR","LU2272731782.SGD","LU2362541273.HKD","LU2468319806.SGD","LU1992135472.HKD","LU1974910355.USD","LU2272731865.HKD","LU0053666078.USD","LU0058720904.USD","BBH","LU0289960550.SGD","LU0057025933.USD","LU2237438978.USD","TBXU","LU1303367103.USD","LU1720051017.SGD","LU2106854487.HKD","LU2089984988.USD","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660796854","title":"Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660796854","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660796854?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:10","pubTimestamp":1787181028,"startTime":"0","endTime":"0","summary":"Telix swings to H1 FY26 net profit of US$38 million; revenue rises 22% to US$477 millionTelix Pharmaceuticals reported H1 2026 revenue of US$477 million, up 22% year over year.Net profit swung to US$3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLbYKwmX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU2023250504.SGD","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU2362540622.SGD","LU2362541273.HKD","LU0320765992.SGD","LU2106854487.HKD","BK7067","BK4139","BK4588","LU0823434740.USD","LU0058720904.USD","LU0114720955.EUR","LU2362541513.USD","LU1974910355.USD","REGN","LU0053666078.USD","LU0109394709.USD","LU0823416689.USD","TLX.AU","LU2468319806.SGD","LU2237438978.USD","BBH","LU0823434583.USD","LU2089984988.USD","LU0882574055.USD","LU1917777945.USD","IBB","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660647872","title":"Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2660647872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660647872?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:06","pubTimestamp":1787169960,"startTime":"0","endTime":"0","summary":"Regeneron to webcast management presentation at Wells Fargo Healthcare ConferenceRegeneron to present at the 2026 Wells Fargo Healthcare Conference on Sept. 9, 2026 at 8:45 a.m. ET.Management to appea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL2xh7x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2106854487.HKD","LU2362541513.USD","REGN","IE00BKPKM429.USD","LU2468319806.SGD","LU0058720904.USD","LU0889565916.HKD","BK4112","BCDF","LU0823434740.USD","IE00B3QW5Z07.USD","BK4588","IE00BQXX3D17.EUR","LU2237438978.USD","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","LU0053666078.USD","LU0289739699.SGD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","LU2023250504.SGD","LU0109394709.USD","LU0823416689.USD","NDAQ","IBB","IE00BQXX3F31.USD","LU0320765992.SGD","LU0882574055.USD","BBH","IBBQ","IE00BN0W2W23.USD","LU0823434583.USD","LU2089984988.USD","SG9999014039.USD","TBXU","LU0314104364.USD","LU2362541273.HKD","SG9999014013.SGD","BK4139","SG9999014021.USD","LU1974910355.USD","IE00BQXX3C00.GBP","LU2362540622.SGD","SG9999014005.SGD","BK4585","LU0114720955.EUR","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473213","title":"Regeneron Announces Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473213","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473213?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:05","pubTimestamp":1787169900,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., Aug.  19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management participation as follows: 2026 Wells Fargo Healthcare Conference at 8:45 a.m. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347966/0/en/regeneron-announces-investor-conference-presentations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0823434583.USD","IBBQ","LU0058720904.USD","LU0823416689.USD","BK4588","LU1974910355.USD","LU0109394709.USD","BBH","IBB","LU0882574055.USD","LU2362541273.HKD","LU0053666078.USD","LU2106854487.HKD","LU2362541513.USD","REGN","BK4585","LU0823434740.USD","LU2468319806.SGD","LU0289739699.SGD","LU2023250504.SGD","BK4139","LU2362540622.SGD","LU0889565916.HKD","LU2237438978.USD","LU1917777945.USD","LU0114720955.EUR","LU0320765992.SGD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660742032","title":"Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2660742032","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660742032?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:27","pubTimestamp":1787164025,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  has received approval from the US Food and Drug Administration for Pasatru to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, or FOP, the drugmaker said Wednesday.FOP is an ultra-rare genetic disorder in which rogue bone formation progressively infiltrates muscles, tendons, ligaments and other connective tissues, causing loss of mobility and potentially making basic activities such as walking, eating and breathing difficult, the company said.The approval was based on phase 3 OPTIMA trial results showing Pasatru reduced new heterotopic ossification lesions by 90% at the 10 mg per kg dose and 94% at the 3 mg per kg dose versus placebo at 56 weeks, the company said.Clinician-assessed flare-ups fell 88% with the 10 mg/kg dose and 15% with the 3 mg per kg dose, the company said.Price: 840.95, Change: +30.71, Percent Change: +3.79","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0823416689.USD","LU0289739699.SGD","LU2468319806.SGD","BBH","TBXU","LU1974910355.USD","REGN","LU0889565916.HKD","LABU","LU2362541513.USD","LU1917777945.USD","LU0882574055.USD","LU2362540622.SGD","LU0823434740.USD","LU2362541273.HKD","BK4585","BK4139","LU0823434583.USD","IBBQ","IBB","BK4588","LU0053666078.USD","LU2237438978.USD","LU0114720955.EUR","LU2089984988.USD","LU0058720904.USD","LU2023250504.SGD","LU2106854487.HKD","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660272694","title":"US FDA Approves Regeneron's Rare Bone Disorder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2660272694","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660272694?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162562,"startTime":"0","endTime":"0","summary":"US FDA approves Regeneron's rare bone disorder drugAug 19-The U.S. Food and Drug Administration on Wednesday approved Regeneron'sREGN.Oexperimental treatment fora rare genetic disorder after the drug significantly reduced abnormal bone formation in certain soft tissues.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G1JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU0289739699.SGD","LU2468319806.SGD","BBH","TBXU","LU1974910355.USD","REGN","LU0889565916.HKD","LU2362541513.USD","LU1917777945.USD","LU0882574055.USD","LU2362540622.SGD","LU0823434740.USD","LU2362541273.HKD","BK4585","BK4139","LU0823434583.USD","IBBQ","IBB","BK4588","LU0053666078.USD","LU2237438978.USD","LU0114720955.EUR","LU2089984988.USD","LU0058720904.USD","LU2023250504.SGD","LU2106854487.HKD","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660264427","title":"Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660264427","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660264427?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162537,"startTime":"0","endTime":"0","summary":"Regeneron says FDA approves Pasatru for adults with rare bone disorder FOPRegeneron won FDA clearance for Pasatru (garetosmab-grts) to curb new HO lesions, clinician-assessed flare-ups in adults with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLKHCsC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0058720904.USD","LU1917777945.USD","IBB","REGN","BK4588","LU2362541273.HKD","TBXU","LU2106854487.HKD","BBH","LU2362540622.SGD","LU2237438978.USD","LU0114720955.EUR","LU0289739699.SGD","IBBQ","LU0823434583.USD","LU0889565916.HKD","LU0053666078.USD","LU1974910355.USD","LU0320765992.SGD","LU0823416689.USD","LU0823434740.USD","LU2468319806.SGD","LU0109394709.USD","LU0882574055.USD","LU2023250504.SGD","BK4139","LU2362541513.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427109","title":"Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427109?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU1974910355.USD","LU0109394709.USD","IBB","BK4139","LU2106854487.HKD","LU0058720904.USD","LU0823416689.USD","LU0823434740.USD","LU2362541273.HKD","LU0889565916.HKD","LU1917777945.USD","LU2023250504.SGD","LU0882574055.USD","BBH","LU2362541513.USD","BK4585","BK4588","LU0053666078.USD","LU2237438978.USD","REGN","LU0289739699.SGD","LU0823434583.USD","LU0114720955.EUR","TBXU","LU2362540622.SGD","LU2468319806.SGD","IBBQ","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regeneron.com","stockEarnings":[{"period":"1week","weight":-0.0478},{"period":"1month","weight":0.142},{"period":"3month","weight":0.2918},{"period":"6month","weight":0.016},{"period":"1year","weight":0.3702},{"period":"ytd","weight":0.0289}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.514286,"avgChangeRate":0.03675},{"month":2,"riseRate":0.428571,"avgChangeRate":0.086855},{"month":3,"riseRate":0.457143,"avgChangeRate":-0.043382},{"month":4,"riseRate":0.457143,"avgChangeRate":0.014275},{"month":5,"riseRate":0.611111,"avgChangeRate":0.052257},{"month":6,"riseRate":0.444444,"avgChangeRate":0.006953},{"month":7,"riseRate":0.666667,"avgChangeRate":0.057379},{"month":8,"riseRate":0.555556,"avgChangeRate":0.023391},{"month":9,"riseRate":0.457143,"avgChangeRate":0.023281},{"month":10,"riseRate":0.4,"avgChangeRate":-0.00141},{"month":11,"riseRate":0.542857,"avgChangeRate":0.046018},{"month":12,"riseRate":0.485714,"avgChangeRate":0.043803}],"exchange":"NASDAQ","name":"Regeneron Pharmaceuticals","nameEN":"Regeneron Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Regeneron Pharmaceuticals,REGN,Regeneron Pharmaceuticals股票,Regeneron Pharmaceuticals股票老虎,Regeneron Pharmaceuticals股票老虎国际,Regeneron Pharmaceuticals行情,Regeneron Pharmaceuticals股票行情,Regeneron Pharmaceuticals股价,Regeneron Pharmaceuticals股市,Regeneron Pharmaceuticals股票价格,Regeneron Pharmaceuticals股票交易,Regeneron Pharmaceuticals股票购买,Regeneron Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}